Purespring Therapeutics raises £80/$105 million in a Series

London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …

CouponFollow Extension

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series

6 days from now

London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …

globenewswire.com

$105
OFF

Purespring Bottles Up $105M Series B For Kidney Gene Therapy

6 days from now

Oct 9, 2024 · London-based biotech Purespring Therapeutics plans to bring their kidney-tweaking gene therapy to the clinic with the help of a new £80 million (about $105 million) pool of series …

fiercebiotech.com

$105
OFF

Purespring Therapeutics Ltd.. (10/9/24). "Press Release: Purespring ...

6 days from now

Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised £80/$105 million in a Series B …

life-sciences-europe.com

$105
OFF

Purespring Therapeutics Secures £80/$105M In Series B Funding …

6 days from now

Oct 9, 2024 · Purespring Therapeutics has raised £80/$105 million in a Series B financing round, led by Sofinnova Partners and featuring other prominent investors, to advance its gene …

ainvest.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series B …

6 days from now

London – 9 October 2024 – Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …

purespringtx.com

$105
OFF

Purespring Therapeutics Presents New Preclinical Data On Novel …

6 days from now

Oct 28, 2024 · Purespring recently announced it had raised £80 million ($105 million) in a Series B financing to support the initiation of a Phase I/II clinical trial for IgAN. There is currently no …

purespringtx.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series B …

6 days from now

London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …

yahoo.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series B …

6 days from now

London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …

businessinsider.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series B …

6 days from now

Oct 9, 2024 · Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised £80/$105 million …

icheme.org

$105
OFF

Purespring Therapeutics Raised A $105M Series B Earlier This Month …

6 days from now

Oct 24, 2024 · CEO Julian Hanak describes how Purespring focuses on targeting podocytes, a cell type that plays a role in various kidney diseases. Key preclinical data for the lead IgA …

biotechtv.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series B …

6 days from now

Oct 9, 2024 · Funds raised will support Purespring in advancing its AAV pipeline of gene therapy programmes to treat kidney disease, including its lead programme targeting IgA Nephropathy …

businessupturn.com

$104
OFF

Advancing Gene Therapy For Kidney Disease, Purespring Adds £80M

6 days from now

Oct 10, 2024 · Purespring Therapeutics Ltd. has raised £80 million (US$104.6 million) in a series B, putting it on course to be the first to take a gene therapy for a kidney disease into the clinic. …

bioworld.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series B …

6 days from now

London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised …

synconaltd.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In A Series B …

6 days from now

Oct 9, 2024 · Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in …

yahoo.com

$105
OFF

Purespring Therapeutics Raises £80/$105 Million In Series B …

6 days from now

London, 7 October, 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised £80/$105 …

forbion.com

FAQs about Purespring Therapeutics raises £80/$105 million in a Series Coupon?

Who is purespring Therapeutics?

London – 9 October 2024 - Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases, today announces it has raised £80/$105 million in a Series B financing. ...

Does purespring therapeutics have a series B financing?

Purespring Therapeutics raises £80/$105 million in a Series B financing to transform the treatment of kidney diseases Oversubscribed financing led by Sofinnova Partners in collaboration with Gilde Healthcare, Forbion, British Patient Capital and founding investor Syncona ...

How much funding does purespring therapeutics have?

Purespring Therapeutics has raised $105m in a Series B funding round which will help progress its lead candidate PS-002 to clinic. Purespring will use the $105m funding to advance its lead candidate PS-002 through the clinic. Credit: Pixel-Shot via Shutterstock. ...

Will purespring bring kidney-tweaking gene therapy to the clinic?

London-based biotech Purespring Therapeutics plans to bring their kidney-tweaking gene therapy to the clinic with the help of a new £80 million (about $105 million) pool of series B cash. ...

Who funded purespring?

The Series B funding round was led by Sofinnova Partners in collaboration with Gilde Healthcare, Forbion, British Patient Capital and founding investor Syncona. Purespring launched out of Syncona in 2021 with $45m Series A funding under its belt. ...

How much money did purespring invest in Igan?

The deals, both worth more than $1bn, saw the companies inherit assets set to treat IgAN. In the announcement accompanying the funding, Purespring’s CEO Julian Hanak said: “Nearly one-tenth of the world’s population, around 840 million people, suffer from chronic kidney disease. ...